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be a major component of the causative agent of transmis-
sible spongiform encephalopathies (TSE), also called pri-
on diseases. Proteinase K resistance is a hall mark of
PrPsc (Prusiner et al., 1984) and PrP mutants causing fa-
milial prion diseases (Gauczynski et al., 2002). Molecules
interacting with PrP (for review see Gauczynski et al.,
2001a) that could play a role in the replication of the infec-
tious particle, as well as the precise location where the
conversion from PrPc to PrPsc take place, have to be iden-
tified (Caughey and Raymond, 1991; Telling et al., 1995). It
has been shown that the normal isoform, PrPc, plays a
central role in prion diseases: (i) PrP knockout mice are re-
sistant to prion infection (Büeler et al., 1993); (ii) when
transgenic mice expressing different levels of PrPc are in-
fected with the agent of prion diseases, the duration of the
incubation period is inversely proportional to the level of
PrPc expressed; (iii) the PrP gene of the host controls the
species barrier (Scott et al., 1989; Prusiner, 1993) and (iv)
PrPc expression is necessary for prion-induced neurode-
generation (Brandner et al., 1996). Thus, characterization
of the cellular receptor for the prion protein appears to be
of crucial interest for understanding the mechanisms of
prion replication, CNS invasion, and neurodegeneration
characteristically linked to prion diseases. In the yeast
two-hybrid system, we have identified the 37 kDa precur-
sor (LRP) of the 67 kDa laminin receptor (LR) as a protein
which interacts directly with PrPc (Rieger et al., 1997). Co-
expression of both LRP and PrP in insect and mammalian
cells has confirmed this interaction (Rieger et al., 1997).
Furthermore, the level of LRP, which has been described
previously as a receptor for the Sindbis virus on mam-
malian cells (Wang et al., 1992), is increased in organs that
support prion replication and PrPsc accumulation in ex-
perimental scrapie or bovine spongiform encephalopathy
(BSE)-infected animals (Rieger et al., 1997). In cellular
models including primary cultures and neuronal cell lines,
we demonstrated that LRP acts as the cellular receptor
for PrPc, mediating the binding and internalization of re-
combinant PrPc (Gauczynski et al., 2001b; Hundt et al.,
2001). We identified interaction domains of the cellular
prion protein with LRP and proposed a model for the in-
teraction complex of PrP with LRP/LR. In this model, he-
paran sulfate proteoglycans (HSPGs) would act as co-
factors/co-receptors for the binding and internalization
process of PrP (Hundt et al., 2001) and may account for
the LRP/LR polymorphism. Additional heparan sulfate
binding sites have been identified in the cellular prion pro-
tein (Warner et al., 2002).
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The prion protein (PrP) plays a central role in prion dis-
eases, and identifying its cellular receptor appears to
be of crucial interest. We previously showed in the
yeast two-hybrid system that PrP interacts with the
37 kDa precursor (LRP) of the high affinity 67 kDa
laminin receptor (LR), which acts as the cellular recep-
tor of PrP in cellular models. However, among the vari-
ous isoforms of the receptor that have been identified
so far, those which are present in the central nervous
system and which bind PrP are still unknown. In this
study, we have purified mouse brain fractions enriched
in the laminin receptor and have performed overlay as-
says in order to identify those isoforms that interact
with the prion protein. We demonstrate (i) the pres-
ence, in mouse brain, of several isoforms of the
LRP/LR corresponding to different maturation states
of the receptor (44, 60, 67 and 220 kDa) and (ii) the bind-
ing of all of these isoforms to PrP. Our data strongly
support a physiological role of the laminin receptor/
PrP interaction in the brain and highlight its relevance
for transmissible spongiform encephalopathies.
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A fundamental event in the pathogenesis of human and
animal prion diseases is the conformational modification
of a normal host-encoded protein (PrPc) from a soluble
form to an aggregated, partially protease-resistant form
termed PrPsc enriched in β-sheeted structures (for review
see Prusiner, 1998). The misfolded isoform (PrPsc) of the
prion protein accumulates in the central nervous system
and in other areas, such as the lymphoreticular system,
during the development of the disease. PrPsc is thought to
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The polypeptide predicted from the non-integrin
laminin receptor cDNA sequence consists of 295 amino
acids and the in vitro translation of selectively hybridized
mRNA produced a protein with an apparent molecular
mass of 37 kDa on sodium dodecyl sulfate-polyacry-
lamide gel electrophoresis (SDS-PAGE) (Rao et al., 1989).
However, other isoforms of the laminin receptor, display-
ing higher molecular masses, have also been described
(Castronovo et al., 1991; Landowski et al., 1995; Menard
et al., 1997; Buto et al., 1998). One of these isoforms, the
67 kDa high affinity laminin receptor (LR: presumably the
mature form of the receptor), is thought to arise from the
heterodimerization of its precursor molecule, the 37 kDa
LRP, with a still unidentified molecule (Buto et al., 1998).
The 67 kDa LR is believed to be the functional isoform of
the receptor regarding its ability to mediate strong at-
tachement of cells to laminin (Lesot et al., 1983; Malinoff
and Wicha, 1983; Rao et al., 1983), to be overexpressed
on cancer cell sufaces, and to promote the invasive and
metastatic capacity of these cells (Menard et al., 1997).
Thus, it is of crucial importance to investigate whether
this isoform is normally expressed in mouse brain and
whether this isoform binds PrP.
We prepared brain protein fractions from uninfected
mouse brain homogenates (abbreviated here as AS50:
50% ammonium sulfate fraction) according to Martins
et al. (1997). Using antibodies recognizing specifically the
LRP (W3) and the LR (ab711), we investigated which iso-
forms of the laminin receptor could be detected in the
AS50 brain fraction. With these polyclonal antibodies, we
identified 4 different isoforms of the receptor, migrating at
44 kDa (Figure 1, lane 2), 60 and 67 kDa (Figure 1, lane 1),
and 220 kDa (Figure 1, lane 1). The 44 kDa isoform, which
has been observed previously in cellular extract such as
A431 human epidermoid carcinoma cells, corresponds
to the precursor receptor LRP (Rao et al., 1989; Buto
et al., 1998). The 60 and 67 kDa doublet bands have also
been detected in A431 cellular extract and other cancer
tissues (Castronovo, 1993; Buto et al., 1998). The 60 kDa
peptide was described as a differentially phosphorylated
isoform of the mature 67 kDa Laminin receptor (Buto
et al., 1998). The last isoform, the 220 kDa protein, pre-
sumably corresponds to an oligomeric form of the LR.
The specificity of these antibodies was confirmed since
no bands were detected using the secondary antibody
alone (Figure 1, lane 3). It is interesting to note the differ-
ent spectrum of recognition of the laminin receptor with
the two antibodies used. In the first case, Ab711, a poly-
clonal antibody directed against amino acids 263 – 282 of
the C-terminal domain of human laminin receptor (Wew-
er et al., 1987) recognizes only the higher molecular mass
isoforms of the receptor while the antibody W3 raised
against full-length LRP (Rieger et al., 1997) recognizes
only LRP. This suggests that the corresponding epitopes
are exposed differentially depending on whether the re-
ceptor is in a precursor or mature state, and whether it is
heterodimerized or oligomerized.
We next wanted to identify which laminin receptor iso-
form could interact with PrP. To this end we performed
overlay assays according to Martins et al. (1997) using
human GST-PrP fusion protein (GST-PrP) and the AS50
brain fraction. The integrity of the recombinant protein
was first verified by western blot (Figure 2a, lane 1). For
the overlay, the proteins present in the AS50 fraction
were separated by gel electrophoresis and overlaid with
recombinant GST::PrP. Then, using a polyclonal antibody
directed against GST, we examined the binding of
GST::PrP to several proteins displaying molecular mass-
es of approximately 44 kDa and 60/67 kDa (Figure 2b,
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Fig. 1 Antibodies Directed against the Non-Integrin Laminin
Receptor Recognize Proteins with Molecular Masses of 44, 60,
66, and 220 kDa.
A mouse brain fraction partially purified by ammonium sulfate
precipitation (20 µg) was electrophoretically separated and ana-
lyzed by Western blotting using two polyclonal antibodies rec-
ognizing either the 37 kDa laminin receptor precursor or the ma-
ture 67 kDa laminin receptor. The following polyclonal antibodies
were employed in this study: Ab711, directed against the pep-
tide P20A (PTEDWSAQPATEDWSAAPTA) amino acids 263 – 282
from the C-terminal domain of human laminin receptor cDNA,
and W3, raised against full-length LRP protein.
Methods: purification of murine laminin receptor by successive
ammonium sulfate precipitations. A 20% murine brain ho-
mogenate was prepared as previously described (Martins et al.,
1997). Briefly, mouse brains were homogenized in a 20% ratio in
50 mM Tris-HCl pH 7.4, 0.2% sodium deoxycholate, 0.5% Triton
X-100, 1 mM aproptinin, 1 mM leupeptin, 1 mM PMSF, and 1 mM
benzamidine and then centrifuged at 12 000 g for 30 min. The
supernatant was then subjected to successive precipitations
with 30% and 50% ammonium sulfate salt. The 50% fraction
precipitate (AS50), was then dissolved in 20 mM Tris-HCl, pH 7.
4, and 120 mM NaCl. Protein samples were separated on 12%
SDS-PAGE gels and transferred to nitrocellulose (Schleicher &
Schuell; Dassel, Germany). The nitrocellulose blots were then
blocked in Blotto [phosphate-buffered saline (PBS) containing
5% dry skim milk powder and 0.1% Tween 20] for 1 h and then
rinsed with PBS-Tween. Blots were then exposed for 1 h to anti-
laminin receptor polyclonal antibodies Ab711 (Abcam Ltd.,
Cambridge, UK) and W3 (Rieger et al., 1997). The blots were
washed three times and then exposed to anti-rabbit peroxidase-
coupled secondary antibodies (Southern Biotechnology, Birm-
ingham, USA; diluted 1:10 000). Peroxidase reactions were de-
tected using enhanced chemiluminescence according to
protocols provided by the manufacturer (Amersham). 
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lane 1, arrows). The molecular mass of the bands detect-
ed corresponded exactly to those detected with LRP/LR
antibodies (compare with Figure 1). A mock overlay re-
vealed no unspecific binding of the anti-GST antibody to
the AS50 brain fraction (Figure 2b, lane 2). In order to
strengthen the finding that PrP binds to proteins exhibit-
ing characteristic molecular masses for the different LR
isoforms in SDS-PAGE (Figure 1), we repeated the over-
lay assay using [35S]-radiolabeled GST::PrP which gives a
better resolution of the signal. Validating our previous re-
sults, the [35S]-labeled GST::PrP bound to several pro-
teins migrating in the gel at 60 kDa, 67 kDa, 220 kDa, and
weakly to the 44 kDa protein (Figure 2c, lane 1), again
demonstrating the interaction between PrP and the
laminin receptor. As a control, the specific interaction of
GST::PrP to the proteins of the AS50 fraction was verified
using [35S]-radiolabeled GST (Figure 2c, lane 2).
In this study, we identified those isoforms of the high
affinity laminin receptor that are expressed in the murine
central nervous system and showed that all these iso-
forms interact with PrP. We demonstrated the specific
binding of both non-radiolabeled and radiolabeled
GST::PrP to the 44, 60/67, and 220 kDa isoforms. The
60/67 kDa isoform, referred to as the mature isoform, is
considered to be the functional entity. Therefore, these
results are suggestive of an effective role of the
PrP/67 kDa LR interaction in the metabolism of PrPc and
presumably its pathological counterpart PrPsc. Hence,
further investigations of the laminin receptor as a poten-
tial therapeutic target for TSE pathologies have to be
considered. Moreover, a parallel can be established be-
tween our present demonstration and a previously pub-
lished study demonstrating the binding of PrP to a
60/66 kDa protein found in the AS50 murine brain fraction
(Martins et al., 1997). In their study, Martins et al. exploit-
ed a concept called complementary hydropathy, by
which peptides encoded by complementary DNA
strands bind to each other, and can be used to produce
peptides that mimic the binding site of a receptor. Sur-
prisingly, both receptor candidates, i.e. the laminin re-
ceptor and the protein isolated by complementary hy-
dropathy (Martins et al., 1997) are found in the 50%
ammonium sulfate brain extract, share the same elec-
trophoresis pattern with a doublet band at 60/67 kDa,
and exhibit the same PrP binding properties in overlay
assays. The 66 kDa band of the protein isolated by com-
plementary hydropathy was recently identified as the
murine stress-inducible protein 1 (STI1) (Zanata et al.,
2002).
Our study confirms that the non-integrin 67 kDa
laminin receptor is present in murine brain and that it
binds PrP. This fact along with our previous study
(Gauczynski et al., 2001b) demonstrating that the laminin
receptor acts as the cell surface receptor internalizing
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Fig. 2 All Proteins Recognized by Anti-Laminin Receptor Antibodies in the AS50 Brain Fraction Bind PrP.
(a) Verification of the integrity of the recombinant GST::PrP band probed with the PrP-specific antibody 3F4 (lane1). (b) Proteins from the
AS50 brain extract were separated by Western blot and overlaid either with recombinant GST::PrP (lane 1) or with control solution
(lane 2). The binding of the GST::PrP was visualized with a polyclonal antibody directed against GST. (c) Overlay of [35S]-radiolabeled
GST::PrP (lane 1) and GST (lane 2) on immobilized proteins of the AS50 brain fraction.
Methods: all overlay assays were performed on nitrocellulose blots with proteins separated by SDS-PAGE. Blots were incubated with
4 µg/ml of recombinant GST::PrP in PBS containing 0.05% Tween 20 for 3 h at room temperature. After three washes in PBS-Tween
(0.05%), the immunoblots were further incubated with an anti-GST polyclonal antibody for 1 h. The reactive bands were visualized with
anti-rabbit peroxidase-coupled antibodies. Immunoblots were developed by enhanced chemiluminescence. Overlay assays accom-
plished with [35S]-radiolabeled proteins were performed using the same methodology without antibodies, and revealed by exposing X-
ray films to the blots. 
Purification and expression of heterologous proteins (GST::PrP and GST): recombinant GST::huPrP23-230 was synthesized in Sf9 cells
by infection with the recombinant baculovirus AcSG2T::huPrP23-230 and radiolabeled in the presence of [35S]-methionine as described
for the GST::haPrP23-231 (Weiss et al., 1995). Radiolabeling of GST was performed as for GST::huPrP23-230. Both proteins were puri-
fied to homogeneity as previously described in Weiss et al. (1995).
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PrP supports the crucial role of this receptor as the cell
surface receptor for the prion protein in the brain. In order
to better comprehend the pathogenesis of prion diseases
and to allow new approaches in therapeutics, the physi-
ological role of the interaction of PrP with the various iso-
forms of the receptor (44, 60/67 and 220 kDa) will have to
be examined by further biochemical and cell biological
studies. 
Acknowledgments
This study was supported by grants BIOMED PL-97-6054 and
QLRT-2000-02085 of the European Union. S. Weiss acknowl-
edges the support by grants 01-KO-0106, 0312876 (BMBF),
LMU 3 and 4 (Bavarian Prion Research Foundation) and thanks
R. Grosschedl and E.-L. Winnacker for valuable advice and con-
tinuous support.
References
Brandner, S., Isenmann, S., Raeber, A., Fischer, M., Sailer, A.,
Kobayashi, Y., Marino, S., Weissmann, C., and Aguzzi, A.
(1996). Normal host prion protein necessary for scrapie-in-
duced neurotoxicity. Nature 379, 339 – 343.
Büeler, H., Aguzzi, A., Sailer, A., Greiner, R.A., Autenried, P.,
Aguet, M., and Weissmann, C. (1993). Mice devoid of PrP are
resistant to scrapie. Cell 73, 1339 – 1347.
Buto, S., Tagliabue, E., Ardini, E., Magnifico, A., Ghirelli, C., van
den Brule, F., Castronovo, V., Colnaghi, M.I., Sobel, M.E., and
Menard, S. (1998). Formation of the 67-kDa laminin receptor
by acylation of the precursor. J. Cell. Biochem. 69, 244 – 251.
Castronovo, V. (1993). Laminin receptors and laminin-binding
proteins during tumor invasion and metastasis. Invasion
Metastasis 13, 1 – 30.
Castronovo, V., Taraboletti, G., and Sobel, M.E. (1991). Func-
tional domains of the 67-kDa laminin receptor precursor. J.
Biol. Chem. 266, 20440 – 20446.
Caughey, B., and Raymond, G.J. (1991). The scrapie-associated
form of PrP is made from a cell surface precursor that is both
protease and phospholipase-sensitive. J. Biol. Chem. 266,
18217 – 18223.
Gauczynski, S., Hundt, C., Leucht, C., and Weiss, S. (2001a). In-
teraction of prion proteins with cell surface receptors, molec-
ular chaperones and other molecules. Adv. Prot. Chem. 57,
229 – 272.
Gauczynski, S., Peyrin, J.M., Haik, S., Leucht, C., Hundt, C.,
Rieger, R., Krasemann, S., Deslys, J.P., Dormont, D., Las-
mezas, C.I., and Weiss, S. (2001b). The 37-kDa/67-kDa
laminin receptor acts as the cell-surface receptor for the cel-
lular prion protein. EMBO J. 20, 5863 – 5875.
Gauczynski, S., Krasemann, S., Bodemer, W., and Weiss, S.
(2002). Recombinant human prion protein mutants huPrP
D178N/M129 (FFI) and huPrP+9OR (fCJD) reveal proteinase
K resistance. J. Cell. Sci. 115, 4025 – 4036.
Hundt, C., Peyrin, J.M., Haik, S., Gauczynski, S., Leucht, C.,
Rieger, R., Riley, M.L., Deslys, J.P., Dormont, D., Lasmezas,
C.I., and Weiss, S. (2001). Identification of interaction domains
of the prion protein with its 37-kDa/67-kDa laminin receptor.
EMBO J. 20, 5876 – 5886.
Landowski, T.H., Dratz, E.A., and Starkey, J.R. (1995). Studies of
the structure of the metastasis-associated 67 kDa laminin
binding protein: fatty acid acylation and evidence supporting
dimerization of the 32 kDa gene product to form the mature
protein. Biochemistry 34, 11276 – 11287.
Lesot, H., Kühl, U., and von der Mark, K. (1983). Isolation of a
laminin-binding protein from muscle cell membranes. EMBO
J. 2, 861 – 865.
Malinoff, H.L., and Wicha, M.S. (1983). Isolation of a cell surface
receptor protein for laminin from murine fibrosarcoma cells. J.
Cell. Biol. 96, 1475 – 1479.
Martins, V.R., Graner, E., Garcia-Abreu, J., Souza, S.J.D., Mer-
candante, A.F., Veiga, S.S., Zanata, S.M., Neto, V.M., and
Brentani, R.R. (1997). Complementary hydropathy identifies a
cellular prion protein receptor. Nature Med. 3, 1376 – 1382.
Menard, S., Castronovo, V., Tagliabue, E., and Sobel, M.E.
(1997). New insights into the metastasis-associated 67 kD
laminin receptor. J. Cell. Biochem. 67, 155 – 165.
Prusiner, S.B. (1993). Transgenetic investigations of prion dis-
eases of humans and animals. Phil. Trans. R. Soc. Lond. 339,
239 – 254.
Prusiner, S.B. (1998). Prions. Proc. Natl. Acad. Sci. USA 95,
13363 – 13383.
Prusiner, S.B., Groth, D.F., Bolton, D.C., Kent, S.B., and Hood,
L.E. (1984). Purification and structural studies of a major
scrapie prion protein. Cell 38, 127 – 134.
Rao, C.N., Castronovo, V., Schmitt, M.C., Wewer, U.M., Clay-
smith, A.P., Liotta, L.A., and Sobel, M.E. (1989). Evidence for a
precursor of the high-affinity metastasis-associated murine
laminin receptor. Biochemistry 28, 7476 – 7486.
Rao, N.C., Barsky, S.H., Terranova, V.P., and Liotta, L.A. (1983).
Isolation of a tumor cell laminin receptor. Biochem. Biophys.
Res. Commun. 111, 804 – 808.
Rieger, R., Edenhofer, F., Lasmezas, C.I., and Weiss, S. (1997).
The human 37-kDa laminin receptor precursor interacts with
the prion protein in eukaryotic cells. Nature Med. 3, 1383 –
1388.
Scott, M.R.D., Foster, D., Mirenda, C., Serban, D., Coufal, F.,
Walchii, M., Torchia, M., Groth, D., Carlson, G., DeArmond,
S.J., Westaway, D., and Prusiner, S.B. (1989). Transgenic mice
expressing hamster prion protein produce species-specific
scrapie infectivity and amyloid plaques. Cell 59, 847 – 857.
Telling, G.C., Scott, M., Mastrianni, J., Gabizon, R., Torchia, M.,
Cohen, F.E., DeArmond, S.J., and Prusiner, S.B. (1995). Prion
propagation in mice expressing human and chimeric PrP
transgenes implicates the interaction of cellular PrP with an-
other protein. Cell 83, 79 – 90.
Wang, K.S., Kuhn, R.J., Strauss, E.G., Ou, S., and Strauss, J.H.
(1992). High-affinity laminin receptor is a receptor for Sindbis
virus in mammalian cells. J. Virol. 66, 4992 – 5001.
Warner, R.G., Hundt, C., Weiss, S., and Turnbull, J.E. (2002).
Identification of the heparan sulfate binding sites in the cellu-
lar prion protein. J. Biol. Chem. 277, 18421 – 18430.
Weiss, S., Famulok, M., Edenhofer, F., Wang, Y.H., Jones, I.M.,
Groschup, M., and Winnacker, E.L. (1995). Overexpression of
active Syrian golden hamster prion protein PrPc as a glu-
tathione S-transferase fusion in heterologous systems. J. Vi-
rol. 69, 4776 – 4783.
Wewer, U.M., Taraboletti, G., Sobel, M.E., Albrechtsen, R., and
Liotta, L.A. (1987). Role of laminin receptor in tumor cell mi-
gration. Cancer Res. 47, 5691 – 5698.
Zanata, S.M., Lopes, M.H., Mercadante, A.F., Hajj, G.N., Chiari-
ni, L.B., Nomizo, R., Freitas, A.R., Cabral, A.L., Lee, K.S., Ju-
liano, M.A. et al. (2002). Stress-inducible protein 1 is a cell sur-
face ligand for cellular prion that triggers neuroprotection.
EMBO J. 21, 3307 – 3316.
Received January 31, 2002; accepted December 2, 2002
246 S. Simoneau et al.
Bereitgestellt von | Universitaetsbibliothek der LMU Muenchen
Angemeldet | 129.187.254.47
Heruntergeladen am | 18.11.13 12:18
